4
Changes in Ownership
Oric Pharmaceuticals, Inc. Filed Acc 0001695028-25-000008
Chief Financial Officer sold 10,720 shares at $9.06 ($97,127)
- Chief Financial Officer acquired 29,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Piscitelli Dominic Chief Financial Officer | 2025-12-15 | Option exercise | +29,333 | 78,868 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2025-12-16 | Sale | −10,720 | $9.06 | $97,127 | 68,148 | D |
| Derivatives | |||||||
| Piscitelli Dominic Chief Financial Officer | 2025-12-15 | Option exercise · Restricted Stock Unit | −8,000 | 0 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2025-12-15 | Option exercise · Restricted Stock Unit | −10,000 | 10,000 | D | ||
| Piscitelli Dominic Chief Financial Officer | 2025-12-15 | Option exercise · Restricted Stock Unit | −11,333 | 22,667 | D | ||
| Open-market sales · 10,720 sh · avg $9.06 · $97,127 | |||||||
Loading xslF345X05/form4-12182025_121249.xml…